Literature DB >> 6150205

Captopril during pregnancy.

R Fiocchi, P Lijnen, R Fagard, J Staessen, A Amery, F Van Assche, B Spitz, M Rademaker.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1984        PMID： 6150205     DOI： 10.1016/s0140-6736(84)91581-2

Source DB:  PubMed          Journal:  Lancet        ISSN： 0140-6736            Impact factor:   79.321


× No keyword cloud information.
  5 in total

1.  Successful pregnancy with scleroderma renal disease and pulmonary hypertension in a patient using angiotensin converting enzyme inhibitors.

Authors:  B A Baethge; R E Wolf
Journal:  Ann Rheum Dis       Date:  1989-09       Impact factor: 19.103

Review 2.  Captopril. An update of its pharmacodynamic and pharmacokinetic properties, and therapeutic use in hypertension and congestive heart failure.

Authors:  R N Brogden; P A Todd; E M Sorkin
Journal:  Drugs       Date:  1988-11       Impact factor: 9.546

Review 3.  Adverse reactions with angiotensin converting enzyme (ACE) inhibitors.

Authors:  R DiBianco
Journal:  Med Toxicol       Date:  1986 Mar-Apr

4.  Effects of captopril on the human foetal placental circulation: an interaction with bradykinin and angiotensin I.

Authors:  R de Moura; M A Lopes
Journal:  Br J Clin Pharmacol       Date:  1995-05       Impact factor: 4.335

5.  Molecular Simulation Elaborating the Mechanism of 1β-Hydroxy Alantolactone Inhibiting Ubiquitin-Conjugating Enzyme UbcH5s.

Authors:  Youdong Xu; Xianli Meng
Journal:  Sci Rep       Date:  2020-01-10       Impact factor: 4.379
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.